Archive · 13 Aug 2025
Delhi Court Rejects Bail Plea in Counterfeit Ozempic Case
Someone was selling fake versions of the diabetes drug Ozempic to other countries.
A court in India said they can't get out of trouble by claiming the crime happened somewhere else.
The fake drugs caused a lot of problems and cost a company a lot of money.
The court wants to protect India's drug industry because it's important for the country and for people's health.
The person in charge tried to use legal papers from India to make the fake drug scheme look real.
A Delhi court dismissed the anticipatory bail plea of a man, Vicky Ramancha, involved in an international counterfeit Ozempic drug racket.
Ramancha is accused of orchestrating a criminal conspiracy to supply fake drugs to foreign entities.
The court emphasized the importance of protecting India's pharmaceutical industry and public health.
The Economic Offences Wing investigation suggests the fraud caused approximately $19 million in losses.
The accused argued over territorial jurisdiction, but the court dismissed the plea, citing the use of Indian legal processes in the scheme.
- Who
- Vicky Ramancha, accused of orchestrating an international counterfeit drug scheme.
- What
- Delhi court denied anticipatory bail for a man involved in a fake Ozempic drug racket.
- When
- Information not provided in the articles.
- Where
- Delhi, India and internationally.
- Why
- To protect India's pharmaceutical industry, public health, and prevent financial losses.
Defendant's Argument
Court's Decision
Jurisdiction
Defendant's Argument
All actions occurred outside India.
Court's Decision
The court deemed that Indian legal systems were used to support the fraudulent activities.
- Drug involved
- Counterfeit Ozempic
- Accused
- Vicky Ramancha
- Alleged Crime
- International counterfeit drug supply
- Financial Loss
- $19 million (approximate)
- Court
- Delhi Court
- Complainant
- Assure Global LLC